MFDS’s active support on developing orphan drugs for Korean pharmas
The Ministry of Food and Drug Safety(MFDS) will make various systematic support plans to promote Korean pharmaceutical companies to expand their business into the orphan drug market which globally records a high 10% growth rate.
According to the Korea Health Industry Development Institute(KHDI),...
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.